Mylan N.V. (NASDAQ:MYL) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Wednesday.

MYL has been the topic of several other reports. Zacks Investment Research raised Mylan N.V. from a “sell” rating to a “hold” rating in a research report on Tuesday, August 1st. Cowen and Company reaffirmed a “market perform” rating and set a $43.00 price target (down from $55.00) on shares of Mylan N.V. in a research report on Sunday, May 21st. UBS AG reaffirmed a “buy” rating and set a $46.00 price target (down from $50.00) on shares of Mylan N.V. in a research report on Thursday, August 10th. Citigroup Inc. raised Mylan N.V. from a “neutral” rating to a “buy” rating and increased their price target for the stock from $36.00 to $42.00 in a research report on Wednesday. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $33.00 price target (down from $41.00) on shares of Mylan N.V. in a research report on Friday, August 4th. Two analysts have rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Mylan N.V. currently has a consensus rating of “Buy” and an average target price of $47.73.

Mylan N.V. (NASDAQ MYL) traded up 1.13% during mid-day trading on Wednesday, hitting $30.47. The company’s stock had a trading volume of 8,994,741 shares. The company has a market cap of $16.34 billion, a P/E ratio of 24.63 and a beta of 1.27. Mylan N.V. has a 12-month low of $29.39 and a 12-month high of $49.42. The firm’s 50-day moving average is $36.59 and its 200-day moving average is $38.90.

Mylan N.V. (NASDAQ:MYL) last released its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.18 by $0.08. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The firm had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. During the same period in the previous year, the company earned $1.16 earnings per share. Mylan N.V.’s revenue was up 15.7% on a year-over-year basis. Analysts predict that Mylan N.V. will post $4.51 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/08/16/mylan-n-v-myl-cut-to-strong-sell-at-bidaskclub.html.

In related news, insider Anthony Mauro sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $400,000.00. Following the transaction, the insider now directly owns 140,653 shares of the company’s stock, valued at approximately $5,626,120. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, President Rajiv Malik sold 25,000 shares of the firm’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the completion of the transaction, the president now directly owns 799,855 shares in the company, valued at $31,994,200. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. raised its position in shares of Mylan N.V. by 3,447.5% in the first quarter. BlackRock Inc. now owns 38,822,643 shares of the company’s stock worth $1,513,696,000 after buying an additional 37,728,274 shares in the last quarter. Pzena Investment Management LLC acquired a new stake in Mylan N.V. during the first quarter worth approximately $283,158,000. Vanguard Group Inc. increased its stake in Mylan N.V. by 12.0% in the second quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock worth $1,276,432,000 after buying an additional 3,531,974 shares during the last quarter. TIAA CREF Investment Management LLC increased its stake in Mylan N.V. by 187.3% in the first quarter. TIAA CREF Investment Management LLC now owns 4,315,668 shares of the company’s stock worth $168,268,000 after buying an additional 2,813,653 shares during the last quarter. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management acquired a new stake in Mylan N.V. during the second quarter worth approximately $84,364,000. 71.57% of the stock is currently owned by hedge funds and other institutional investors.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.